课题基金 / 基金详情

The role of cross presentation in viral infection

The role of cross presentation in viral infection
交叉呈递在病毒感染中的作用
批准号:
179593469
负责人:
Professor Dr. Thomas Brocker
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2010
资助国家:
德国
项目状态:
已结题
起止时间:
2009-12-31 至 2013-12-31

项目摘要

项目成果

Professor Dr. Thomas Brocker的其他基金

相似基金

相关文献

中文摘要
翻译
“交叉呈递”描述了外源性抗原经由I类MHC呈递给CD 8 T细胞。这一机制解释了如何通过对自身抗原的耐受诱导来灭活自身反应性CD 8 T细胞。此外,交叉呈递似乎允许产生针对外源性肿瘤抗原或源自病毒的抗原的细胞毒性T细胞应答,所述外源性肿瘤抗原或源自病毒的抗原可抑制感染的树突状细胞并抑制直接MHC I呈递。虽然几种细胞类型似乎能够交叉呈递抗原,但树突状细胞是最有效的。然而,尽管做出了许多努力,交叉呈递对控制病毒感染和疫苗接种的贡献仍不清楚。使用转基因小鼠与树突状细胞不能交叉表达外源性抗原和单纯疱疹病毒-以及鼠巨细胞病毒-突变体缺乏基因的免疫失活的组合,我们将研究交叉呈递在初级和记忆CD 8 T细胞反应中的作用。这项研究的结果将与免疫系统功能的基本理解以及疫苗的合理设计有关。
英文摘要
“Cross-presentation” describes the presentation of exogenous antigen via MHC class I to CD8 T cells. This mechanism explains how inactivation of self-reactive CD8 T cells by tolerance induction to self-antigen might occur. In addition, cross-presentation seems to allow the generation of cytotoxic T cell responses to exogenous tumour antigens or antigens derived from virus, which can inactivate infected Dendritic Cells and inhibit direct MHC I presentation. Although several cell types seem to be able to cross-present antigens, Dendritic Cells are most potent to do so. However, despite many efforts, the contribution of cross-presentation to control of viral infections and vaccination is still unclear. Using a combination of transgenic mice with dendritic cells unable to crosspresent exogenous antigens and Herpes-Simplex-Virus- as well as Murine Cytomegalovirus-mutants lacking genes contributing to immune inactivation, we will study the role of cross-presentation in primary and memory CD8 T cell responses. The outcome of this study will be relevant for the basic understanding of the functioning of the immune system, as well as the rational design of vaccines.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3389/fimmu.2012.00348
发表时间: 2012-01-01
期刊: FRONTIERS IN IMMUNOLOGY
影响因子: 7.3
作者: [Nopora, Katrin, Bernhard, Caroline A., Brocker, Thomas]
通讯作者: Brocker, Thomas
The influence of antigen distribution on quality and repertoire of CD8+ T cell responses
  • 批准号:
    200114013
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2011
  • 负责人:
    Professor Dr. Thomas Brocker
  • 依托单位:
Untersuchung der Rolle von bcl-2 Expression in dendritischen Zellen bei Induktion und Regulierung der Immunantwort in vivo
  • 批准号:
    5327828
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2001
  • 负责人:
    Professor Dr. Thomas Brocker
  • 依托单位:
Immunologie
  • 批准号:
    5124480
  • 项目类别:
    Heisenberg Fellowships
  • 资助金额:
    $0.0万
  • 财政年份:
    1999
  • 负责人:
    Professor Dr. Thomas Brocker
  • 依托单位:
国内基金
海外基金
胰岛素样生长信号介导的肺巨噬细胞和上皮细胞cross-tolk通过核自噬参与慢性气道炎症形成的机制研究
  • 批准号:
    JCZRYB202500229
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
基于NLRP3炎性小体与自噬Cross-talk探讨心康冲剂干预心肌纤维化的机制研究
PKM2琥珀酰化修饰介导癌细胞与血小板间Cross-talk调控胆管癌侵袭转移的研究
  • 批准号:
    JCZRYB202500379
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位: